Form 4: Moderna President Stephen Hoge Sells 15,000 Shares Under 10b5-1 Trading Plan

Moderna's President, Stephen Hoge, sold 15,000 shares of common stock at $105.02 per share on April 15, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Summary

• On April 15, 2024, Stephen Hoge, President of Moderna, Inc., sold 15,000 shares of Moderna's common stock.
• The sale was executed at a price of $105.02 per share.
• This transaction was conducted under a pre-arranged Rule 10b5-1 trading plan adopted on March 15, 2023.
• Following the transaction, Hoge directly owns 1,486,241 shares of Moderna's common stock.
• Hoge also has indirect ownership through Valhalla, LLC (4,116 shares) and a trust for his spouse and children (151,933 shares).

Sentiment

Score: 5

Explanation: The document is a standard SEC Form 4 filing, indicating a routine stock sale under a pre-arranged trading plan. It doesn't inherently convey positive or negative sentiment.

Industry Context

Executive stock sales are a common occurrence in publicly traded companies. Monitoring these transactions can provide insights into management's perspective on the company's valuation and future prospects. Rule 10b5-1 plans allow insiders to sell shares over a predetermined period, mitigating concerns about trading on non-public information.

Key Dates